The global meningococcal vaccine market is poised for robust growth, with an estimated valuation of USD 3950.2 million in 2024, projected to reach approximately USD 9014 million by 2034. This reflects a significant compound annual growth rate (CAGR) of 8.6% over the forecast period from 2024 to 2034. The growth of the meningococcal vaccine market …
Continue reading “Meningococcal Vaccine Market to Reach USD 9014 Million by 2034 at a 8.6% of CAGR”